M. Pollak

First name
M.
Last name
Pollak
Suissa, S. ., Azoulay, L. ., Dell’Aniello, S. ., Evans, M. ., Vora, J. ., & Pollak, M. . (2011). Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia. http://doi.org/10.1007/s00125-011-2190-9
Azoulay, L. ., Dell’Aniello, S. ., Gagnon, B. ., Pollak, M. ., & Suissa, S. . (2011). Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-10-0940
Azoulay, L. ., Eberg, M. ., Benayoun, S. ., & Pollak, M. . (2015). 5alpha-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer. JAMA Oncol. http://doi.org/10.1001/jamaoncol.2015.0387
Wu, J. W., Azoulay, L. ., Majdan, A. ., Boivin, J. F., Pollak, M. ., & Suissa, S. . (2017). Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes. J Clin Oncol. http://doi.org/10.1200/jco.2017.73.4491